Identification of CYP2C9 and VKORC1 polymorphisms in Iranian patients who are under warfarin therapy

Background: Although catalytic properties of different genetic polymorphisms of VKORC1 and CYP2C9 products have been identified, there is limited study available regarding warfarin dose requirement in Iranian patient population. This study investigates the impact of these polymorphisms on 115 patien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Hematol Oncol Stem Cell Res
Main Authors: Poopak, Behzad, Rabieipoor, Saghar, Safari, Nazila, Naraghi, Emadedin, Sheikhsofla, Fatemeh, Khosravipoor, Gelareh
Formato: Artigo
Idioma:Inglês
Publicado em: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4748690/
https://ncbi.nlm.nih.gov/pubmed/26865929
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados